Monod Bio
Seattle, WA
Monod Bio is a pioneer company in the design of de novo protein biosensors. Our innovative biosensor platform technology takes advantage of the most recent advances in computational protein engineering to create highly modular biosensing nanoswitches that enable rapid, sensitive, and inexpensive analytical assays. Our visionary founding team and state-of-the-art technology position Monod Bio at the forefront of biosensor innovation, and we welcome exceptional individuals to join us in this journey.
monod.bioCompany Details
Founded
- 2021
Employees
- Between 20 - 50 employees
Raised
- $27,250,000
Headquarters Location
- Seattle, WA
Public
- No
Acquired
- No
CEO
Daniel-Adriano S.
Founders
- Alfredo Quijano RubioDavid ShoultzDaniel-Adriano S.David Baker
Company Collections
These are collections Monod Bio is a part of. Click on the collection name to view similar companies.
Monod Bio's Industries
Monod Bio's Tech Stack
Monod Bio Headquarters Location
Total Amount Raised: $27,250,000
Monod Bio Funding Rounds
Grant
$750,000
Grant Investors
Bill & Melinda Gates FoundationGrant
$1,500,000
Grant Investors
Bill & Melinda Gates FoundationSeed
$25,000,000
Seed Investors
Matrix Capital ManagementPack VenturesCercano ManagementSahsen VenturesWashington Research FoundationBOOM Capital. SiteGlobal Health Investment
Monod Bio Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Monod Bio.